Previous 10 | Next 10 |
Theravance Biopharma to Report Second Quarter 2022 Financial Results on August 4, 2022 PR Newswire DUBLIN , July 28, 2022 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2022 financial results and provide a busines...
Theravance Biopharma Announces Tender Offer For Outstanding 3.25% Convertible Senior Notes Due 2023 PR Newswire DUBLIN , July 26, 2022 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced a te...
Theravance Biopharma ( TBPH ) +14% to buy royalty interest in Trelegy drug from Theravance, Innoviva for $1.3B. TransGlobe Energy ( TGA ) +9% agrees to acquire TransGlobe Energy in all stock deal. Payoneer Global ( PAYO ) +8% . Marinus Pharm...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com We’re diving into all the latest stock market news with a breakdown of the biggest pre-market stock movers for Thursday! Moving stocks this morning is merger news, right ...
Further diversifies Royalty Pharma’s portfolio with market-leading respiratory therapy Expected to significantly add to long-term Adjusted Cash Receipts growth ( 1) ( non-GAAP) NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma pl...
Theravance Biopharma to Sell TRELEGY ELLIPTA Royalty Interests to Royalty Pharma for Approximately $1.1 Billion in Upfront Cash with Over $1.5 Billion in Potential Total Value PR Newswire Over $1.5 Billion in Potential Total Value, Including Approximately $1.1 ...
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective July 11, 2022. His appointment brings the company’s board of directors to ten members...
SVB Leerink analyst Geoffrey Porges initiated coverage of Theravance Biopharma (TBPH +5.4%) with an Outperform rating and $12 price target. The analyst expects shares to outperform as the company delivers strong financial momentum and the Street more appropriately discounts the intrinsic...
Seth Klarman’s 13F portfolio value decreased from $10.13B to $9.30B this quarter. Baupost Group increased Fiserv, Dropbox, Encompass Health, Nuvation Bio, and ironSource while reducing Joby Aviation and dropping Pershing Square Tontine and NortonLifeLock. The portfolio cont...
Theravance Biopharma, Inc. (TBPH) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Gail Cohen – Vice President-Corporate Communications Rick Winningham – Chairman and Chief Executive Officer Rhonda Farnum – Senior Vice President and Chief Busin...
News, Short Squeeze, Breakout and More Instantly...
Theravance Biopharma Inc. Company Name:
TBPH Stock Symbol:
NASDAQ Market:
Theravance Biopharma Inc. Website:
2024-06-15 00:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update PR Newswire Q1 2024 YUPELRI ® (revefenacin) net sales of $55.2 million , recognized by Viatris, increased 18% from Q1 2023 1 Viatris collaboratio...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...